Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2020-09-16
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
With this study the investigators aim to validate these findings in a larger cohort.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epigenetic Changes in Head and Neck Cancer
NCT04260074
Proteome- and Methylation Profiles in Oropharyngeal Cancer
NCT04567082
Validation of DNA Methylation Biomarkers for Oral Cancer Detection
NCT01945697
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
NCT00898664
Validation of DNA Methylation Biomarkers for Oral Cancer Detection
NCT02648789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cancer group
Patients with verified head and neck squamous cell carcinomas
Blood sample
A separate blood sample will be taken for methylation-analyses
Control group
Matched control group without active or earlier cancer and a normal ENT examination.
Blood sample
A separate blood sample will be taken for methylation-analyses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sample
A separate blood sample will be taken for methylation-analyses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Verified head and neck squamous cell carcinoma
* Written informed consent
* Normal ENT-examination
Exclusion Criteria
* Uncontrolled comorbidity
* Unable to give informed consent
Control group:
* Other active cancer
* Uncontrolled comorbidity
* Unable to give informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aalborg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christian Sander Danstrup
Associate Professor, M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Gaihede, Professor
Role: PRINCIPAL_INVESTIGATOR
Department of Otolaryngology - Head and Neck Surgery, Aalborg University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Otolaryngology - Head and Neck Surgery
Aalborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Michael Gaihede, Professor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20190047-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.